ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Self-assembly nanoplatform of platinum (IV) prodrug for enhanced ovarian cancer therapy

Ma, Xiao; Liu, Yangjia; Wu, Hanmei; Tan, Jinxiu; Yi, Wenying; Wang, Zhenjie*; Yu, Zhiqiang*; Wang, Xuefeng*广东省人民医院; 南方医科大学
Materials Today Bio2023-8DOI: 10.1016/j.mtbio.2023.100698
1被引10阅读
引用收藏
分享

摘要

Cisplatin is a metal platinum complex commonly used in the field of anti-tumor and one of the most commonly used drugs in combination chemotherapy. However, chemotherapy with Cisplatin induced overexpression of cyclooxygenase-2 (COX-2) protein in tumor cells, which could impair the therapeutic effect of chemotherapy on tumor progression. Here, we presented a novel method for the treatment of ovarian cancer with a self-assembly based nano-system. Cisplatin and tolfenamic acid were each linked to linoleic acid to give them the ability to selfassemble into nanoparticles in water. TPNPs had flexible drug ratio adjustability, homogeneous stability, and high drug loading capacity. Compared with Cisplatin, TPNPs could promote cellular uptake and tumor aggregation, coinduce enhanced apoptosis and tumor growth inhibition by inhibiting COX-2 in the mice xenograft model of human ovarian cancer, and reduce systemic toxicity. Therefore, TPNPs is a promising antitumor drug as a kind of self-assembly nano-prodrug with high drug load.

学科与关键词

关键词
CisplatinCOX-2 inhibitorTolfenamic acidSynergistic therapyNanoprodrug
相关
加载中…
  • Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer
    Wang, Yupeng; Luo, Zhijian; Zhou, Dongfang; Wang, Xuefeng; Chen, Jianjun; Gong, Shipeng; Yu, Zhiqiang*Biomaterials Science, 2021, 9(11): 4110-4119.被引 19
  • Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway
    Luo, Zhijian; Luo, Yantao; Liang, Xiaoling; Lyu, Qingyang; Meng, Fanliang; Chen, Xuncai; Wang, Yupeng; Fang, Weiyi*; Li, Aimin*; Zhou, Dongfang*ACS Biomaterials Science & Engineering, 2022, 8(6): 2526-2536.
  • Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP
    Liu, Yuan; Wang, Yiru; Guan, Xue; Wu, Qiong; Zhang, Mengjun; Cui, Ping; Wang, Can; Chen, Xiuwei*; Meng, Xianwei*; Ma, Tengchuang*ACS applied materials & interfaces, 2023, 15(22): 26484-26495.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Materials Today Bio
发表日期
2023-08
卷期
第 21 卷
页码
100698
DOI
10.1016/j.mtbio.2023.100698
成果收录
SCIE
资助标注
GDNRC (Guangdong nature resource center) [(2020) 037]; Natural Science Foundation of Guangdong Province [22019A1515011498, 2019A1515011619]; Institute of Applied Chemistry of CAS; Animal Laboratory Center of Southern Medical University

作者

  • M

    Ma, Xiao (第一作者)

    guangdong prov peoples hosp · southern med univ

  • L

    Liu, Yangjia

    southern med univ

查看全部 8 位作者收起作者
  • W

    Wu, Hanmei

    southern med univ

  • T

    Tan, Jinxiu

    southern med univ

  • Y

    Yi, Wenying

    southern med univ

  • W

    Wang, Zhenjie (通讯)

  • Y

    Yu, Zhiqiang (通讯)

    southern med univ

  • W

    Wang, Xuefeng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417